Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Brossart

Showing results (131-140 of 266) with videos related to

Pageof 27
Sort By:
British Journal of Haematology|November 16, 2022
Nestin expression in osteocytes following myeloablation and during bone marrow metastasisRuth-Miriam Koerber, Rebekka K Schneider, Jessica Ellen Pritchard, et al.
The Prostate|October 4, 2019
The value of tumor markers in men with metastatic prostate cancer undergoing [<sup>177</sup> Lu]Lu-PSMA therapyAnna Yordanova, Paula Linden, Stefan Hauser, et al.
Blood|May 8, 2004
CD63 tetraspanin slows down cell migration and translocates to the endosomal-lysosomal-MIICs route after extracellular stimuli in human immature dendritic cellsAdriana R Mantegazza, María Marcela Barrio, Sandrine Moutel, et al.
British Journal of Haematology|October 3, 2002
Human cytomegalovirus induces a direct inhibitory effect on antigen presentation by monocyte-derived immature dendritic cellsUlrich Grigoleit, Susanne Riegler, Hermann Einsele, et al.
Journal of Cancer Research and Clinical Oncology|September 16, 2021
Blastic plasmacytoid dendritic-cell neoplasia: a challenging case reportRuth-Miriam Koerber, Stefanie A E Held, Maria Vonnahme, et al.
Plos One|June 5, 2015
The VEGF-Receptor Inhibitor Axitinib Impairs Dendritic Cell Phenotype and FunctionAnnkristin Heine, Stefanie Andrea Erika Held, Solveig Nora Daecke, et al.
The Journal of Antimicrobial Chemotherapy|January 29, 2010
Overall survival and fungal infection-related mortality in patients with invasive fungal infection and neutropenia after myelosuppressive chemotherapy in a tertiary care centre from 1995 to 2006Corinna Hahn-Ast, Axel Glasmacher, Sara Mückter, et al.
Blood|February 11, 2003
Survivin is a shared tumor-associated antigen expressed in a broad variety of malignancies and recognized by specific cytotoxic T cellsSusanne M Schmidt, Kerstin Schag, Martin R Müller, et al.
European Journal of Haematology|February 13, 2020
Long-term follow-up of Cladribine, high-dose Cytarabine, and Idarubicin as salvage treatment for relapsed acute myeloid leukemia and literature reviewKarin Mayer, Corinna Hahn-Ast, Katjana Schwab, et al.
Journal of Nanobiotechnology|July 13, 2016
A liposomal formulation of the synthetic curcumin analog EF24 (Lipo-EF24) inhibits pancreatic cancer progression: towards future combination therapiesSavita Bisht, Martin Schlesinger, Alexander Rupp, et al.
Pageof 27

Showing results (131-140 of 266) with videos related to

Sort By:
Pageof 27
British Journal of Haematology|November 16, 2022
Nestin expression in osteocytes following myeloablation and during bone marrow metastasisRuth-Miriam Koerber, Rebekka K Schneider, Jessica Ellen Pritchard, et al.
The Prostate|October 4, 2019
The value of tumor markers in men with metastatic prostate cancer undergoing [<sup>177</sup> Lu]Lu-PSMA therapyAnna Yordanova, Paula Linden, Stefan Hauser, et al.
Blood|May 8, 2004
CD63 tetraspanin slows down cell migration and translocates to the endosomal-lysosomal-MIICs route after extracellular stimuli in human immature dendritic cellsAdriana R Mantegazza, María Marcela Barrio, Sandrine Moutel, et al.
British Journal of Haematology|October 3, 2002
Human cytomegalovirus induces a direct inhibitory effect on antigen presentation by monocyte-derived immature dendritic cellsUlrich Grigoleit, Susanne Riegler, Hermann Einsele, et al.
Journal of Cancer Research and Clinical Oncology|September 16, 2021
Blastic plasmacytoid dendritic-cell neoplasia: a challenging case reportRuth-Miriam Koerber, Stefanie A E Held, Maria Vonnahme, et al.
Plos One|June 5, 2015
The VEGF-Receptor Inhibitor Axitinib Impairs Dendritic Cell Phenotype and FunctionAnnkristin Heine, Stefanie Andrea Erika Held, Solveig Nora Daecke, et al.
The Journal of Antimicrobial Chemotherapy|January 29, 2010
Overall survival and fungal infection-related mortality in patients with invasive fungal infection and neutropenia after myelosuppressive chemotherapy in a tertiary care centre from 1995 to 2006Corinna Hahn-Ast, Axel Glasmacher, Sara Mückter, et al.
Blood|February 11, 2003
Survivin is a shared tumor-associated antigen expressed in a broad variety of malignancies and recognized by specific cytotoxic T cellsSusanne M Schmidt, Kerstin Schag, Martin R Müller, et al.
European Journal of Haematology|February 13, 2020
Long-term follow-up of Cladribine, high-dose Cytarabine, and Idarubicin as salvage treatment for relapsed acute myeloid leukemia and literature reviewKarin Mayer, Corinna Hahn-Ast, Katjana Schwab, et al.
Journal of Nanobiotechnology|July 13, 2016
A liposomal formulation of the synthetic curcumin analog EF24 (Lipo-EF24) inhibits pancreatic cancer progression: towards future combination therapiesSavita Bisht, Martin Schlesinger, Alexander Rupp, et al.
Pageof 27